Toll Like Receptor 4: A Potential Link Between Obesity and Metabolic Diseases
Obesity Reviews · 2026
DOI: 10.1111/obr.70107 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, 2026. Verfasst von Ghadeer Alhamar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Dasman Diabetes Institute, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Obesity, Toll-Like Receptor 4, Inflammation, Metabolic Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epidemiological evidence shows that obesity increases the risk of developing metabolic diseases. Nevertheless, the mechanisms behind this connection remain underappreciated. The substantial impact of these disorders on global health has led to extensive research efforts aimed at identifying the pathophysiological links between them. Chronic low‐grade inflammation, induced by altered secretion of adipokines and other bioactive molecules, from adipose tissue, is believed to causally link obesity to various metabolic disorders. Multiple studies have indicated that TLR4 regulates inflammation, adipogenesis, thermogenesis, and glucose metabolism through its interaction with endotoxins, particularly in the context of obesity. The increased expression of TLR4 observed in obesity is believed to contribute to the development of type 2 diabetes (T2D), as it disrupts key physiological processes that regulate metabolic inflammation. This review aims to summarize recent research on the pathobiological roles of TLR4‐mediated inflammation in obesity and its contribution to the development of metabolic disorders. Overall, current evidence supports a central role for TLR4 as a mediator of obesity‐associated metabolic inflammation, highlighting TLR4 and its downstream pathways as promising targets for preventing or treating obesity related metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, Dasman Diabetes Institute, Kuwait City, Kuwait.
- INSERM UMR-S1151, CNRS UMR-S8253, Université Paris Cité, Institut Necker Enfants Malades, Paris, France.
- Department of Bioenergetics and Neurometabolism, Dasman Diabetes Institute, Kuwait City, Kuwait.
- Department of Translational Research, Dasman Diabetes Institute, Kuwait City, Kuwait.
Zitieren
APA
Alhamar, G., Razafiarison, J., Alzaid, F., Al-Mulla, F., & Ahmad, R. (2026). Toll Like Receptor 4: A Potential Link Between Obesity and Metabolic Diseases. Obesity Reviews. https://doi.org/10.1111/obr.70107
Vancouver
Alhamar G, Razafiarison J, Alzaid F, Al-Mulla F, Ahmad R. Toll Like Receptor 4: A Potential Link Between Obesity and Metabolic Diseases. Obesity Reviews. 2026. doi:10.1111/obr.70107
BibTeX
@article{Alhamar2026,
author = {Alhamar, Ghadeer and Razafiarison, Joanna and Alzaid, Fawaz and Al-Mulla, Fahd and Ahmad, Rasheed},
title = {Toll Like Receptor 4: A Potential Link Between Obesity and Metabolic Diseases},
journal = {Obesity Reviews},
year = {2026},
doi = {10.1111/obr.70107}
}
EUVIMED